Medication

Bioidentical Hormone Replacement Therapy

Also known as:

BHRT, Bioidentical HRT

Bioidentical hormone replacement therapy (BHRT) uses hormones molecularly identical to those the body makes, individualized for menopause and perimenopause symptoms.

SLOT: Full Definition

What is bioidentical hormone replacement therapy?

Bioidentical hormone replacement therapy — often called BHRT or bioidentical HRT — uses hormones whose molecular structure is identical to the hormones the human body produces naturally. The most commonly replaced hormones are Estradiol, Progesterone Bioidentical (oral micronized progesterone), and sometimes Testosterone Therapy Women and Dhea. BHRT is most often used during Perimenopause and Menopause to restore hormones that decline as ovarian function changes.

At Modern Thyroid Clinic, BHRT is a cornerstone of women's hormone care. It is individualized — there is no single "menopause dose" — and dosing, route, and combination depend on each woman's symptoms, labs, history, and goals.

Bioidentical vs. synthetic hormones

This distinction matters and is often misunderstood:

  • Bioidentical hormones have the same molecular structure as endogenous human hormones. Examples include estradiol patches, gels, and pills; oral micronized progesterone (Prometrium); and compounded testosterone creams.
  • Synthetic hormones have a different molecular structure designed to mimic some hormone effects. Examples include conjugated equine estrogens (Premarin) and progestins like medroxyprogesterone (Provera).

Both categories can be FDA-approved or compounded. Bioidentical does not automatically mean compounded, and compounded does not automatically mean safer. FDA-approved bioidentical estradiol patches and oral micronized progesterone are widely available, well-studied, and generally first-line.

The historical concerns about HRT — particularly the cardiovascular and breast cancer signals from the Women's Health Initiative — were generated almost entirely with synthetic conjugated estrogen plus a synthetic progestin, started years past menopause. Bioidentical formulations have a different, generally more favorable safety profile when started in or near the perimenopausal-to-menopausal transition.

When is BHRT prescribed?

BHRT is considered for women experiencing:

  • Hot flashes, night sweats, sleep disruption
  • Vaginal dryness, painful sex, urinary symptoms
  • Brain fog, mood changes, anxiety, low motivation
  • Joint aches, skin changes, hair thinning
  • Bone loss or strong family history of osteoporosis
  • Significant quality-of-life impact from perimenopause or menopause

Dosing is highly individualized — labs, symptoms, age, time since last period, breast and cardiovascular history, and personal goals all factor in.

Patient considerations

BHRT is generally well-tolerated when prescribed thoughtfully. Routes matter: transdermal estradiol carries lower clotting risk than oral; oral micronized progesterone is preferred over synthetic progestins for endometrial protection. BHRT is not appropriate for women with active breast cancer, certain clotting disorders, or unexplained vaginal bleeding without evaluation. Periodic monitoring — labs, breast exams, blood pressure — is important.

BHRT is one tool, not a magic fix. At MTC we pair it with thyroid optimization, nutrition, strength training, and stress work. The decision to start, dose, or change BHRT should always be individualized with a clinician.

Common symptoms

Common questions

Is BHRT safer than traditional HRT?

For most women, the bioidentical formulations now used as standard care — transdermal estradiol plus oral micronized [progesterone-bioidentical] — appear to have a more favorable safety profile than the synthetic combinations studied in the original Women's Health Initiative. Transdermal estradiol does not raise clotting risk the way oral synthetic estrogens do, and oral micronized progesterone has not shown the breast cancer signal seen with synthetic progestins. "Safer" depends on the specific formulation, route, dose, age at initiation, and individual risk factors. The decision should always be individualized with a clinician.

Do I need compounded hormones to do BHRT?

Usually not. Most women can be treated successfully with FDA-approved bioidentical products: estradiol patches, gels, or oral tablets, plus oral micronized progesterone (Prometrium). FDA-approved products have rigorous quality and dose consistency. Compounded BHRT can be valuable for women who need a non-standard dose, a specific combination, or a route (such as testosterone for women) that no FDA-approved product currently provides in the right strength. Compounded does not automatically mean better, and salivary hormone testing protocols promoted by some compounded-only clinics are not validated. Modern Thyroid Clinic uses both, matching the form to the patient.

When should I start BHRT — perimenopause or menopause?

Often during [perimenopause], when symptoms commonly begin — sometimes years before periods stop. The "timing hypothesis" suggests starting BHRT closer to the menopausal transition, generally within 10 years of the last period or before age 60, has the most favorable cardiovascular and cognitive risk-benefit profile. Waiting until severe symptoms or many years past menopause may still be appropriate but the calculations shift. The right time is whenever symptoms or risk factors (such as bone loss) justify treatment in your specific situation. This is a deeply individual decision best made with a clinician who knows your history.

Think you might be dealing with this?

Talk to a Modern Thyroid Clinic specialist about your symptoms, labs, and next steps.

Book a Discovery Call

This content is for educational purposes only and is not medical advice. Consult a licensed clinician for diagnosis and treatment. Content on this page does not create a doctor-patient relationship with Modern Thyroid Clinic.